BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 31-Jan-2018

(Q2 Un-audited): EPS was Tk. 4.26 for October-December, 2017 as against Tk. 2.90 for October-December, 2016; EPS was Tk. 8.05 for July-December, 2017 as against Tk. 4.90 for July-December, 2016. NOCFPS was Tk. 3.35 for July-December, 2017 as against Tk. (1.03) for July-December, 2016. NAV per share was Tk. 55.23 as on December 31, 2017 and Tk. 49.53 as on June 30, 2017.

PHARMAID 24-Jan-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2017.

PHARMAID 01-Jan-2018

National Credit Ratings Limited (NCR) has announced the Surveillance Rating of the Company as "A-" in the long term and "ST-3" in the short term along with a stable outlook based on audited financial statements of the Company as on June 30, 2017.

PHARMAID 07-Dec-2017

In response to a DSE query dated December 06, 2017, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.

PHARMAID 04-Dec-2017

Trading of the shares of the Company will resume on 05.12.2017 after record date.

PHARMAID 03-Dec-2017

Trading of the shares of the Company will remain suspended on record date i.e., 04.12.2017.

PHARMAID 29-Nov-2017

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 30.11.2017 to 03.12.2017. Trading of the shares of the Company will remain suspended on record date i.e., 04.12.2017.

PHARMAID 15-Nov-2017

(Q1 Un-audited): EPS was Tk. 3.80 for July-September, 2017 as against Tk. 2.00 for July-September, 2016; NOCFPS was Tk. 1.89 for July-September, 2017 as against Tk. (0.70) for July-September, 2016. NAV per share was Tk. 53.30 as on September 30, 2017 and Tk. 49.53 as on June 30, 2017.

PHARMAID 12-Nov-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

PHARMAID 12-Nov-2017

There will be no price limit on the trading of the shares of the Company today (12.11.2017) following its corporate declaration.

Previous Next page